phosphoserine has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, JY; Hsin, CH; Hsu, TC; Huang, CH; Lee, CF; Lee, YJ; Lin, TH; Wu, WJ; Yao, TY | 1 |
1 other study(ies) available for phosphoserine and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide
| Article | Year |
|---|---|
TGF-beta inhibits prolactin-induced expression of beta-casein by a Smad3-dependent mechanism.
Topics: Animals; Apoptosis; Benzamides; Caseins; Cells, Cultured; Dioxoles; Epithelial Cells; Gene Expression Regulation; Genes, Dominant; Humans; Janus Kinase 2; Mammary Glands, Animal; Phosphoserine; Phosphothreonine; Phosphotyrosine; Prolactin; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Smad3 Protein; STAT5 Transcription Factor; Transforming Growth Factor beta | 2008 |